 |
Epigenetics and human health : linking hereditary, environmental and nutritional aspects / edited by Alexander G. Haslberger, co-edited by Sabine Cressler. — Weinheim : Wiley-VCH, c2010. – (63.141/E64h) |
Contents
Contents
Preface XV
List of Contributors XVII
Part I General Introduction
1 The Research Program in Epigenetics: The Birth of a New Paradigm
References 5
2 Interactions Between Nutrition and Health
2.1 Introduction 7
2.2 Epigenetic Effects of the Diet 8
2.3 Current Nutrition Related Health Problems
References 9
3 Epigenetics: Comments from an Ecologist 11
References 12
4 Interaction of Hereditary and Epigenetic Mechanisms in the Regulation of Gene Expression 13
4.1 Hereditary Dispositions 13
4.2 The Epigenome 14
4.3 Epigenetic Mechanisms 15
4.4 Environmental Influences 20
4.5 Dietary Effects 22
4.6 Inheritance and Evolutionary Aspects 28
4.7 Conclusion 29
References 30
Part II Hereditary Aspects
5 Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphisms and Cancer Risk: A Review of the Published Meta-Analyses 37
5.1 Key Concepts of Population-Based Genetic Association Studies 37
5.2 Methylenetetrahydrofolate Reductase Gene Polymorphisms (C677T and A1298C) and Its Association with Cancer Risk 41
5.3 Meta-Analyses of Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphisms and Cancer 44
References 47
6 The Role of Biobanks for the Understanding of Gene-Environment Interactions 51
6.1 Background 51
6.2 The Investigation of Gene-Environment Interactions as a Challenge for Biobanks
References 60
7 Case Studies on Epigenetic Inheritance 63
7.1 Introduction 64
7.2 Methodology 65
7.3 Patterns of Transgenerational Responses 70
7.4 Epigenetic Inheritance
7.5 Future Directions 80
7.6 Conclusions 81
References 83
Part III Environmental and Toxicological Aspects
8 Genotoxic， Non-Genotoxic and Epigenetic Mechanisms in Chemical Hepatocarcinogenesis: Implications for Safety Evaluation 89
8.1 Introduction 90
8.2 Genotoxic and Non-Genotoxic Chemicals in Relation to the Multistage Model of Cancer Development 91
8.3 Concluding Remarks 97
References 99
9 Carcinogens in Foods: Occurrence， Modes of Action and Modulation of Human Risks by Genetic Factors and Dietary Constituents 105
9.1 Introduction 105
9.2 Genotoxic Carcinogens in Human Foods 106
9.3 Contribution of Genotoxic Dietary Carcinogens to Human Cancer Risks 111
9.4 Protective Effects of Dietary Components Towards DNA-Reactive Carcinogens
9.5 Gene Polymorphisms Affecting the Metabolism of Genotoxic Carcinogens 114
9.6 Concluding Remarks， Epigenetics and Outlook 118
References 118
Part IV Nutritional Aspects
10 From Molecular Nutrition to Nutritional Systems Biology 127
10.1 Impact of Life Sciences on Molecular Nutrition Research 127
10.2 Nutrigenomics 129
10.3 Nutrigenetics 133
10.4 Nutri-Epigenetics 135
10.5 Nutritional Systems Biology 137
10.6 Ethics and Socio-Economics of Modern Nutrition Research 137
References 139
11 Effects of Dietary Natural Compounds on DNA Methylation Related to Cancer Chemoprevention and Anticancer Epigenetic Therapy 141
11.1 Introduction 141
11.2 DNA Methylation Reaction 142
11.3 Implication of the Selected Natural Compounds in DNA Methylation Regulation
11.4 Conclusions and Future Perspectives 151
References 152
12 Health Determinants Throughout the Life Cycle 157
12.1 Introduction 157
12.2 Pre- and Postnatal Determinants 159
12.3 Determinants During Infancy and Adulthood 160
12.4 Determinants in Adults and Older People 160
12.5 Interactions Throughout the Lifecycle 161
12.6 Intergenerational Effects 161
References 162
Part V Case Studies
13 Viral Infections and Epigenetic Control Mechanisms 167
13.1 The Evolutionary Need for Control Mechanisms 167
13.2 Control by RNA Silencing 168
13.3 Viral Infections and Epigenetic Control Mechanisms 169
13.4 Epigenetics and Adaptive Immune Responses 171
References 171
14 Epigenetics Aspects in Gyneacology and Reproductive Medicine 173
References 178
15 Epigenetics and Tumorigenesis
15.1 Introduction 179
15.2 Role of Metabolism Within the Epigenetic Network 181
15.3 Epigenetic Modification by DNA Methylation During Lifetime 183
15.4 Interaction of Genetic and Epigenetic Mechanisms in Cancer 184
15.5 DNA Methylation in Normal and Cancer Cells 185
15.6 Promoter Hypermethylation in Hematopoietic Malignancies 186
15.7 Hypermethylated Gene Promoters in Solid Cancers 187
15.8 Interaction DNA Methylation and Chromatin 188
References 190
16 Epigenetic Approaches in Oncology 195
16.1 Introduction 195
16.2 DNA Methylation， Chromatin and Transcription 196
16.3 Methods for Detecting Methylation 197
16.4 The Paradigm of Lung Cancer 198
16.5 Epigenetics and Therapy 200
16.6 Epigenetic Alterations Under Cytotoxic Stress 201
16.7 Therapeutic Applications of Inhibitors of DNA Methylation 202
16.8 How May Methylation Become Relevant to Clinical Applications? 203
16.9 Conclusions 204
References 205
17 Epigenetic Dysregulation in Aging and Cancer 209
17.1 Introduction 210
17.2 The Cancer-Prone Metabolic Phenotype of Aging 210
17.3 Age-Related Epigenetic Silencing Via DNA Methylation 212
17.4 Inflammatory Control of Age-Related Epigenetic Regulators 214
17.5 Lessons from Anti-Aging Modalities 215
17.6 Conclusions 217
References 218
18 The Impact of Genetic and Environmental Factors in Neurodegeneration: Emerging Role of Epigenetics 225
18.1 Neurodegenerative Diseases 225
18.2 The Role of Causative and Susceptibility Genes in Neurodegenerative Diseases
18.3 The Contribution of Environmental Factors to Neurodegenerative Diseases
18.4 Epigenetics， Environment and Susceptibility to Human Diseases 233
18.5 Epigenetics and Neurodegenerative Diseases 234
18.6 The Epigenetic Role of the Diet in Neurodegenerative Diseases 237
18.7 Concluding Remarks 238
References 239
19 Epigenetic Biomarkers in Neurodegenerative Disorders 245
19.1 Introduction 245
19.2 Epigenetic Marks in Inherited Neurological and Neurodegenerative Disorders
19.3 Epigenetic Dysregulation in Neurodegenerative Disorders 247
19.4 Gene Candidates for Epigenetic Biomarkers 248
19.5 Conclusions 249
References 250
20 Epigenetic Mechanisms in Asthma 253
20.1 Introduction 253
20.2 Epigenetic Mechanisms 255
20.3 Fetal Basis of Adult Disease 255
20.4 Fetal Basis of Asthma 256
20.5 Experimental Evidence 257
20.6 Epigenetic Mechanisms in Asthma 257
20.7 Cell-Specific Responses 259
20.8 Conclusion 259
References 260
Part VI Ways to Translate the Concept
21 Public Health Genomics - Integrating Genomics and Epigenetics into National and European Health Strategies and Policies 267
21.1 Public Health and Genomics 267
21.2 The Bellagio Model of Public Health Genomics 268
21.3 The Public Health Genomics European Network 271
21.4 From Public Health Genomics to Public Health and Epigenetics/Epigenomics 272
21.5 Health in All Policies-Translating Epigenetics/Epigenomics into Policies and Practice 272
21.6 Health in All Policies as a Guiding Concept for European Policies 273
21.7 Relative Risk and Risk Regulation - A Model for the Regulation of Epigenetic Risks? 274
21.8 Attributable Risks and Risk Regulation 275
21.9 Translating Attributable Risks into Policies 275
21.10 Limits to the Concept of Health in All Policies in Genomics and Epigenetics
21.11 Conclusion 278
References 278
22 Taking a First Step: Epigenetic Health and Responsibility 281
22.1 Introduction 281
22.2 Responding to Epigenetic Challenges 282
22.3 Responsibility and Public Health Care Policy 283
22.4 Conclusion 284
References 285
Index 287
